54 related articles for article (PubMed ID: 12567091)
1. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
Lei Y; An J; Ren Q; Wang M; Gao M
Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
[TBL] [Abstract][Full Text] [Related]
2. The Hyperproliferation Mechanism of Cholesteatoma Based on Proteomics: SNCA Promotes Autophagy-Mediated Cell Proliferation Through the PI3K/AKT/CyclinD1 Signaling Pathway.
Gao M; Xiao H; Liang Y; Cai H; Guo X; Lin J; Zhuang S; Xu J; Ye S
Mol Cell Proteomics; 2023 Sep; 22(9):100628. PubMed ID: 37532176
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis.
Satoh C; Yoshiura KI; Mishima H; Yoshida H; Takahashi H; Kumai Y
BMC Med Genomics; 2023 Nov; 16(1):288. PubMed ID: 37968650
[TBL] [Abstract][Full Text] [Related]
4. Recurrence in cholesteatoma surgery: what have we learnt and where are we going? A narrative review.
Bovi C; Luchena A; Bivona R; Borsetto D; Creber N; Danesi G
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl 1):S48-S55. PubMed ID: 37698100
[TBL] [Abstract][Full Text] [Related]
5. Morphopathogenesis of Adult Acquired Cholesteatoma.
Dambergs K; Sumeraga G; Pilmane M
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837507
[No Abstract] [Full Text] [Related]
6. Complex Evaluation of Tissue Factors in Pediatric Cholesteatoma.
Dambergs K; Sumeraga G; Pilmane M
Children (Basel); 2021 Oct; 8(10):. PubMed ID: 34682191
[TBL] [Abstract][Full Text] [Related]
7. Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.
Araz Server E; Kalaycık Ertugay Ç; Baykal Koca S; Longur ES; Yiğit Ö; Demirhan H; Çakır Y
J Int Adv Otol; 2019 Apr; 15(1):38-42. PubMed ID: 30541725
[TBL] [Abstract][Full Text] [Related]
8. Superior semicircular canal dehiscence: A new perspective.
Sood D; Rana L; Chauhan R; Shukla R; Nandolia K
Eur J Radiol Open; 2017; 4():144-146. PubMed ID: 29234688
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.
Hamed MA; Nakata S; Shiogama K; Suzuki K; Sayed RH; Nishimura Y; Iwata N; Sakurai K; Badawy BS; Inada KI; Tsuge H; Tsutsumi Y
Clin Exp Otorhinolaryngol; 2017 Sep; 10(3):213-220. PubMed ID: 28073243
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.
Hamed MA; Nakata S; Sayed RH; Ueda H; Badawy BS; Nishimura Y; Kojima T; Iwata N; Ahmed AR; Dahy K; Kondo N; Suzuki K
Clin Exp Otorhinolaryngol; 2016 Dec; 9(4):298-308. PubMed ID: 27440129
[TBL] [Abstract][Full Text] [Related]
11. The c-MYC protooncogene expression in cholesteatoma.
Palkó E; Póliska S; Csákányi Z; Katona G; Karosi T; Helfferich F; Penyige A; Sziklai I
Biomed Res Int; 2014; 2014():639896. PubMed ID: 24683550
[TBL] [Abstract][Full Text] [Related]
12. Aggressiveness of pediatric cholesteatoma. Do we have an evidence?
Lynrah ZA; Bakshi J; Panda NK; Khandelwal NK
Indian J Otolaryngol Head Neck Surg; 2013 Jul; 65(3):264-8. PubMed ID: 24427579
[TBL] [Abstract][Full Text] [Related]
13. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.
Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D
Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896
[TBL] [Abstract][Full Text] [Related]
14. Radiographic features of superior semicircular canal dehiscence in the setting of chronic ear disease.
Gartrell BC; Gentry LR; Kennedy TA; Gubbels SP
Otol Neurotol; 2014 Jan; 35(1):91-6. PubMed ID: 24136312
[TBL] [Abstract][Full Text] [Related]
15. Analysis of histopathological aspects in acquired middle ear cholesteatoma.
Alves AL; Pereira CSB; Ribeiro FAQ; Fregnani JHTG
Braz J Otorhinolaryngol; 2008; 74(6):835-841. PubMed ID: 19582339
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
17. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
19. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
